Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 35 of 35

Filter Applied: atrial fibrillation (Click to remove)

Clinical Presentation, Diagnosis, and Treatment of Atrioesophageal Fistula Resulting From Atrial Fibrillation Ablation
J Cardiovasc Electrophysiol 32:2441-2450, Della Rocca,D.G.,et al, 2021

Neurological Consequences of Atrioesophageal Fistula After Radiofrequency Ablation in Atrial Fibrillation
Arch Neurol 66:884-887, St�llberger,C.,et al, 2009

Case Records of MGH-NEJM 289:366
1973 Tuberculoma of Cerebral hemisphere & Brain Stem., , 1973

Neurologic Manifestations of Bacterial Endocarditis
Ann Int Med 71:21, Jones,H.,et al, 1969

A Rare Complication of Cardiac Ablation:Atrial-esophageal Fistula Presenting as Odynophagia
Cureus doi:10.7759/CUREUS.6871, Khan,M.,et al, 2020

Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: Current Status, Special Situations, and Unmet Needs
Lancet 386:303-310, Verheugt, F.W.A. & Granger, C.B., 2015

New Antithrombotic Drugs for Atrial Fibrillation: Caution is Needed
Lancet 379:e24, Bell,S.,et al, 2012

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
NEJM 367:625-635, Olesen, J.B.,et al, 2012

Clinicopath Conf
Qunidine-Induced Thrombocytopenia, Cerebral Hemorrhage, Case 15-1995, NEJM 332:1363-137095., , 1995

Surgical Treatment of Atrioesophageal Fistula:A Systematic Review
Ann Thorac Surg 116:421-428, Amirkhosravi,F.,et al, 2023

A 62-year-old man with history of catheter ablation presenting with recurrent strokes
Neurol 95:e3065-e3069, Jeanneret, V.,et al, 2020

Neurologic Abnormalities After Atrial Fibrillation Ablative Procedure
JAMA Neurol 75:1144-1145, Stanton, R.J.,et al, 2018

Atrioesophageal Fistula -Clinical Presentation, Procedural Characteristics, Diagnostic Investigations, and Treatment Outcomes
Circ Arrhythrm Electrophysiol doi:10.1161/CIRCEP.117.005579, Han,H-C.,et al, 2017

Primary Prevention of Stroke
JAMA 316:658-659, Steiger, N. & Cifu, A.S., 2016

Secondary Prevention after Ischemic Stroke or Transient Ischemic Attack
NEJM 366:1914-1922;, Davis, S.M. & Donnan, G.A., 2012

Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:227-276, Furie,K.L.,et al, 2011

Apixaban in Patients With Atrial Fibrillation
NEJM 364:806-817, Connolly,S.J.,et al, 2011

Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:512-584, Goldstein,L.B.,et al, 2011

Clincopath Conf, Pheochromocytoma
NEJM 362:1815-1823, Case 14-2010, 2010

Independent Predictors of Stroke in Patients with Atrial Fibrillation
Neurol 69:546-554, The Stroke Risk in Atrial Fibrillation Working Group, 2007

Direct Thrombin Inhibition and Stroke Prevention in Elderly Patients With Atrial Fibrillation: Experience From the SPORTIF III and V Trial
Stroke 38:2965-2971, Ford,G.A.,et al, 2007

Ximelagatran vs Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
JAMA 293:690-698,736, SPORTIF Executive Steering Committee for the SPORTIF V Investigators, 2005

Stroke Prevention with the Oral Direct Thrombin Inhibitor Ximelagatran Compared with Warfarin in Patients with Non-Valvular Atrial Fibrillation (SPORTIF III): Randomised Controlled Trial
Lancet 362:1691-1698,1686, Executive Steering Committee on Behalf of the SPOR, 2003

New Evidence for Stroke Prevention
JAMA 288:1388-1395, Straus,S.E.,et al, 2002

Primary Prevention of Ischemic Stroke
Stroke 32:280-299, Goldstein,L.B.,et al, 2001

Atrial Fibrilation and the Risk of Cerebral White Matter Lesions
Neurol 54:1795-1801, de Leeuw,F.E.,et al, 2000

Prevention of a First Stroke,A Review of Guidelines and a Multidisciplinary Consensus Statement from the National Stroke Association
JAMA 281:1112-1120,1146, Gorelick,P.B.,et al, 1999

Silent Brain Infarction in Nonrheumatic Atrial Fibrillation
EAFT Study Group, Neurol 46:159-1651996., , 1996

Stroke Prevention an Opportunity for Efficient Utilization of Health Care Resources During the Coming Decade
Stroke 25:220-224, Gorelick,P.B., 1994

Predictors of Thromboembolism in Atrial Fibrillation:I. Clinical Features of patients at Risk
The Stroke Prevention in A Fib Investigators, Ann Int Med 116:1-51992., , 1992

Risk Factors for Stroke in Patients with Nonrheumatic Atrial Fibrillation:A Case-Control Study
Am J Med 91:156-161, Moulton,A.W.,et al, 1991

Predisposing Factors for Cerebral Infarction:The Oxfordshire Community Stroke Project
BMJ 298:75-80, Sandercock,P.A.G.,et al, 1989

Ischemic Cerebrovascular Complications of Pregnancy
Arch Neurol 42:1106-1113, Wiebers,D.O., 1985

Importance of Holter Monitoring in Patients with Periodic Cerebral Symptoms
Ann Neurol 1:470, Jonas,S.,et al, 1977

Electrocardiographic Changes & Myocardial Damage in Patients with Acute Cerebrovascular Accidents
Stroke 8:448, Dimant,J.,et al, 1977



Showing articles 0 to 35 of 35